The TLR4 9:117713042 variant showed increased CRC risk, with AG genotype being more frequent in cases versus controls (9.6% vs 1.2%, OR=8.92, 95% CI: 1.14-69.95, p=0.037). This evidence concerns the gene TLR4 and colorectal carcinoma.